Menu
Components of the Scheme
1. Assistance for Common Facilities (CF) To strengthen the medical device clusters’ capacity for their sustained growth by creating Common Infrastructure Facilities.
2. Assistance for Testing Facilities (TF) To strengthen availability of more Medical Device Testing Laboratories in order to boost. manufacturing of quality medical devices
Financial Year | Physical Outlay | Financial Outlay (Rs. in crore) | |||
Common Facilities | Testing labs | Common Facilities | Testing labs | Total Grant-in-Aid | |
2023-24 | 4 | 6 | 48 | 18 | 66 |
2024-25 | 8 | 6 | 128 | 30 | 158 |
2025-26 | 0 | 0 | 64 | 12 | 76 |
Total | 12 | 12 | 240 | 60 | 300 |
For Common Infrastructure Facilities (CIF) for the Medical Device (MD) clusters, the limit of support will be 70% of the approved project cost or Rs. 20 cr., whichever is less, as per the approval of SSC. In the case of Himalayan States and States in the North East Region, the grant-in-aid would be Rs. 20 Crore per Cluster or 90% of the project cost of the CIF, whichever is less.
Incentive under the scheme The limit of incentive will be 70% of the approved project cost or Rs 20 cr., whichever is less, as per approval of SSC. In the case of Himalayan States and States in the North East Region, the grant-in-aid would be Rs. 20 Crore per Cluster or 90% of the project cost of the Common Infrastructure Facilities (CIF), whichever is less
II. Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) To facilitate Micro, Small and Medium Pharma Enterprises (MSMEs) of proven track record to meet national and international regulatory standards.
Existing Pharmaceutical manufacturing units having average turnover less than Rs. 500 crore over the last 3 years.
Pharmaceutical units with the following average turnover criteria over the last three years will be eligible for incentives, subject to a maximum of Rs. 1.00 crore:
Investments made for upgradation after January 1, 2024, will be eligible for subsidy calculation.
For imported machinery, the cost of machinery as investment will include import duty, shipping charges, customs charges, and GST. For domestically purchased machinery, GST will be included in the investment cost.
Only the following expenditures will be considered for subsidy calculation for Pharma units:
WhatsApp us
Automated page speed optimizations for fast site performance